Hypofractionated Stereotactic Radiotherapy (HFSRT) of the Resection Cavity versus Whole-Brain Radiotherapy (WBRT) following Brain Metastasis Resection – Results of the ESTRON Randomized Phase 2 Trial
R. El Shafie, D. Bernhardt, A. Schiele, T. Welzel, D. Schmitt, P. Thalmann, S. Erdem, A. Paul, S.J. Hoene, K. Lang, L. K€onig, F. Weykamp, S. Adeberg, A. Lentz-Hommertgen, C. Jaekel, F. Bozorgmehr, M. Thomas, M. Kieser, J. Debus, and S. Rieken | ASTRO | 2023
Stereotactic Radiosurgery for 1-10 Brain Metastases avoids Whole-Brain Radiotherapy – Results of the CYBER-SPACE Randomized Phase 2 Trial (LBA 12)
R. El Shafie, D. Bernhardt, A. Schiele, T. Welzel, D. Schmitt, P. Thalmann, S. Erdem, A. Paul, S. J. Hoene1, K. Lang, L. König, F. Weykamp, S. Adeberg, A. Lentz-Hommertgen, C. Jaekel, F. Bozorgmehr, M. Thomas, M. Kieser, J. Debus, and S. Rieken | ASTRO | 2023
Stereotactic Radiotherapy vs. Whole Brain Radiation Therapy for Patients with 1-10 Brain Metastases from Small Cell Lung Cancer: Results of the Randomized ENCEPHALON (ARO 2018-9) Trial (LBA 07)
D. Bernhardt, R. El Shafie, M. Thomas, F. Bozorgmehr, A. Schiele, D. Schmitt, T. Welzel, P. Thalmann, A. Paul, L. König, K. Lang, S. Adeberg, S. Höne, F. Weykamp, P. Vollmuth, A. Lentz-Hommertgen, C. Jaekel, U. Nestle, M. Kieser, J. Debus, and S. Rieken | ASTRO | 2023
Helical TomoTherapy Planning Technique Improves Dosimetry for Hippocampal-Avoidant Whole Brain Radiotherapy Compared with VMAT (2217)
D. DiBartolo, K. Spuhler1, O. Clancy, J. Haas, J. W. Lischalk, M. Witten, and T. J. Carpenter | ASTRO | 2023
Artificial Intelligent (AI) Enabled Safe and Efficient Workflow for Multi-Course and Multi-Brain-Metastasis SRS
C Chuang, L Wang, L Liu, S Soltys, E University, N Marianayagam, U Yener, H Jiang, G Szalkowski, L Vitzthum, E Pollom, Q Ho, D Park, A Meola, W Lu | AAPM | 2023
Individual PTV Margin Selection for Simultaneous SRS/SRT of Multiple Brain Metastases (>10): A Study Based on Intra-Fractional Patient Motion Analysis
X Chen, L Chen, C Ma | AAPM | 2023
Stereotactic Radiotherapy with Helical TomoTherapy for Brain Metastasis
S. D’Alessandro, S. D’Alessandro, G. Ferrera, V. Figlia, A. Spera, G. Mortellaro, D. Cespuglio, G. Craparo, G. Tringali, L. Blas5, E. Greco, F. Cuccia | PO-1116 | ESTRO | 2023
Stereotactic Re-irradiation of Relapsed Intracranic Lesions: A Monoinstitutional Experience
Chiara Chissotti et al | PO-1129 | ESTRO | 2023
Robotic Stereotactic Radiotherapy for ≥10 Brain Metastases Treated with Single Treatment Planning
Miriam Torrisi et al | PO-1111 | ESTRO | 2023
Hypofractionated Stereotactic Radiotherapy with or without Whole Brain Radiotherapy with Helical Tomotherapy for Multiple Brain Metastases – Long-Term Follow-Up Results of a Phase II Trial
Yuchao Ma | ASTRO | 2022
Radiosurgery with Helical Tomotherapy: Outcomes for Patients with One or Multifocal Brain Metastasis
Barra S, Agostinelli S, Vagge S, Giannelli F, Siccardi D, Garelli S, Aloi D, Belgioia L, Bosetti D, Zeverino M, Corvò R | Technol Cancer Res Treat | 2015
Radiosurgery Using Tomotherapy for Patients with Brain Oligo-metastasis: A Retrospective Analysis on Feasibility and Tolerance
Bruni A, Gaito S, Ciarmatori A, Lanfranchi B, Mazzeo E, Maffei N, Giacobazzi P, Turco E, Guidi G, Bertoni F | Anticancer Res | 2015
Efficacy of stereotactic radiotherapy for brain metastases using dynamic jaws technology in the helical tomotherapy system
Murai T, Hayashi A, Manabe Y, Sugie C, Takaoka T, Yanagi T, Oguri T, Matsuo M, Mori Y, Shibamoto Y | Br J Radiol | 2016
Intracranial Hemorrhage in Patients with Anticoagulant Therapy Undergoing Stereotactic Radiosurgery for Brain Metastases: A Bi-Institutional Analysis
Felix Ehret, David Kaul, Lucas Mose, Volker Budach, Peter Vajkoczy, Christoph Fürweger, Alfred Haidenberger, Alexander Muacevic, Felix Mehrhof, Markus Kufeld | Cancers (Basel) | 2022
Planning with the CyberKnife® VOLO™ Optimizer: Hear from the experts
Dr Reynolds
Planning for Multiple Brain Metastases with the CyberKnife® System
Daniela Schmitt
The Impact of 1-3 vs ≥ 4 Brain Metastases and Patient, Tumor and Imaging Parameters on Overall Survival after CyberKnife® Radiosurgery
Judith A. Murovic
Multiple Brain Metastases: The Stanford CyberKnife® Experience
Erqi Pollom
Multifraction SRS in the Treatment of Large Brain Oligometastases
Huaguang Zhu
The volumetric response of brain metastases after stereotactic radiosurgery and its post-treatment implications
Sharpton SR, Oermann EK, Moore DT, Schreiber E, Hoffman R, Morris DE, Ewend MG | Neurosurgery | 2014
